December 06, 2006
Pfizer problems emblematic of industry obstacles
NPR Online, December 5, 2006
The decision by Pfizer, the world's largest pharmaceutical company, to abandon work on a promising cholesterol drug has some analysts wondering whether the industry can continue to grow at the same pace. Cardiologist Eric Topol of Case Western Reserve University in Cleveland says it's difficult for the pharmaceutical industry to find a drug that adds meaningful new benefits for someone who is already taking four or five drugs a day, including aspirin, a statin and a blood thinner. Read article.
Posted by: Heidi Cool, December 6, 2006 02:36 PM | News Topics: Health, NPR Online, School of Medicine
http://blog.case.edu/caseinthenews/2006/12/06/pfizer_problems_emblematic_of_industry_obstacles
Office of Marketing and Communications
http://www.case.edu/univrel/marcomm/
216.368.4440
